U.S. Markets open in 1 hr 29 mins

3 Peninsula biotech IPOs show off diversity of targets, seek to raise more than $400 million

Ron Leuty
3 Peninsula biotech IPOs show off diversity of targets, seek to raise more than $400 million

From rare diseases to cancer and NASH, this trio of companies would be the seventh, eighth and nine Bay Area life sciences IPOs this year.